If orforglipron can be manufactured at scale for a fraction of the cost of injectable alternatives, and if its oral format eliminates the injection barriers that prevent millions from starting therapy, the public health impact could be measured in reduced cardiovascular events, fewer diabetes-related amputations, decreased obesity-related cancer incidence, and extended healthy lifespan across populations
Patients typically notice improved energy, better sleep, increased muscle tone, and fat loss within a few weeks, with full benefits developing over 3 to 6 months
The gold standard for measuring bioavailability
Augmentation of neutrophil numbers and function by adding G- CSF, inhibiting CXCR4 and blocking CD47-SIRP interactions may be a therapeutic approach to enhance the function of neutrophils in infections (Nmeth et al., 2020)
"A lot more needs to be done to regulate this space," Dr Yip said